welcome to cyprotex adme
welcome to cyprotex adme
cloe predict
cloe select
cloe screen

Chemical stability with non specific binding assay

Use our chemical stability assay to measure degradation of your compound in aqueous buffer.

The chemical stability assay  is one of our Cloe Screen portfolio of in vitro ADME screening services. Cyprotex deliver consistent, high quality data with cost-efficiency that comes from a highly automated approach.
 

Assessment of chemical stability with non specific binding

  • A compound is chemically unstable when it is degraded by non-enzymatic processes. Degradation may be caused by several mechanisms, the most common being hydrolysis, oxidation, or light-catalysed degradation.
  • Compounds that are highly unstable may not be suitable as drug candidates since it may be difficult to maintain a therapeutically effective formulation.
  • Compounds designed for oral administration must be chemically stable at the low pH values observed in the stomach in order for this to be an acceptable route. A range of different pH values are available.
  • Cloe Screen Chemical Stability assay is combined with an assessment of non specific binding by performing the assay in plates prepared from two different materials with different binding characteristics, polypropylene and PTFE (otherwise known as polytetrafluoroethylene or Teflon®).
  • Both non specific binding to apparatus such as plates or tips and chemical instability can be responsible for inaccurate in vitro data.
 
 
‘At the drug discovery stage, when drug candidates are screened against biological targets, compounds need to have sufficient stability in the assay buffers for enzyme, receptor, or cell-based assays to reliably measure biological activity.’
1Di L, Kerns E.H, Chen H, and Petusky SL. (2006) J Biomol Screen 11 (1) ; 40-47.
Protocol +
Data +
Q&A +
References

1 Di L et al. (2006) J Biomol Screen 11 (1); 40-47.

 
chemical stability

Download a copy of the product sheet

Cloe® is a registered trade mark owned by Cyprotex PLC

careerscontactlegalprivacy
This website was last updated
on 8th September 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.